Early oncology portfolio execution roadmap
The challenge
We worked with our client to develop a forward-looking early development program evaluation tool that identifies key inflection points, value drivers and risks for the client’s early oncology portfolio. (US was the geographic scope).
Our solution
- Developed a dynamic excel-based tool for program evaluation with key dimensions, value, risk, and inflection points over time
- Filled in gaps using external benchmarks including key program metrics such as timing, cost and risk
- Developed standalone commercial forecast and valuation for each program (n=17) accounting for opportunity size, competitive dynamics, pricing, cost and PTRS considerations
- Developed current and future portfolio snapshot and outcomes
- Ensured repeatable process for future updates over time
The results
We delivered a commercial analysis of the portfolio with regards to relative potential of the programs along with their key value drivers, milestones, risks and gaps over a 10-year time horizon for key stakeholders.
Jump to a slide with the slide dots.
Jo Ann Saitta
Accelerated Real-World Insight: How AI and Claims Data Rapidly Turn Gaps into Health Equity Action
AI and claims data bridge health equity gaps in cardiovascular care, uncovering disparities and providing actionable solutions to improve access.
Read morePatient Finding Through Data Tokenization
Refined HCP targeting in rare disease using integrated data, boosting hit rates from 10% to 50% and delivering 3x ROI in 6 months.
Read moreDigital share of voice and sentiment analysis at key congress
Used GenAI to benchmark digital voice in oncology, boosting engagement & leadership via LinkedIn, DEI & clinical messaging.
Read more